丁苯酞软胶囊 | China Drugs ListButylphthalide soft capsules | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 药品类型
- 化学药Chemical medicine
- 治疗领域
- 神经科Neurology
- 公开来源记录的适应症
- 用于治疗轻、中度急性缺血性脑卒中。For mild-to-moderate acute ischemic stroke.
- 适应症来源与口径
- 生产商面向中国大陆的药品说明书。 历史版本说明书；可能未包括后续变更。 批准或修订日期为空或为占位值；尚未确认准确修订日期。Manufacturer prescribing information for Mainland China. Historical label; subsequent changes may not be included. An approval or revision date is blank or a placeholder; the exact revision date is not confirmed.
- 说明书信息局限
- 已取得完整官方药品说明书。 中国大陆说明书。Complete official prescribing information obtained. Mainland China label.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 限新发的急性缺血性脑卒中患者在发作72小时内开始使用，支付不超过20天。Restricted to newly occurring acute ischemic stroke when treatment starts within 72 hours of onset; reimbursement is limited to 20 days.
- 医保期限
- 2025-01-01 至 2026-12-312025-01-01 to 2026-12-31
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.